Halozyme Therapeutics, Inc. (HALO)
112.45
+2.77
(+2.53%)
USD |
NASDAQ |
Sep 18, 16:00
112.95
+0.50
(+0.44%)
After-Hours: 20:00
Halozyme Therapeutics 30-Day Average Daily Volume : 2.301M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.301M |
| September 17, 2026 | 2.052M |
| September 16, 2026 | 2.028M |
| September 15, 2026 | 2.023M |
| September 14, 2026 | 2.034M |
| September 11, 2026 | 2.055M |
| September 10, 2026 | 2.098M |
| September 09, 2026 | 2.103M |
| September 08, 2026 | 2.133M |
| September 04, 2026 | 2.126M |
| September 03, 2026 | 2.148M |
| September 02, 2026 | 2.143M |
| September 01, 2026 | 2.136M |
| August 31, 2026 | 2.143M |
| August 28, 2026 | 2.152M |
| August 27, 2026 | 2.146M |
| August 26, 2026 | 2.165M |
| August 25, 2026 | 2.153M |
| August 24, 2026 | 2.159M |
| August 21, 2026 | 2.150M |
| August 20, 2026 | 2.161M |
| August 19, 2026 | 2.168M |
| August 18, 2026 | 2.166M |
| August 17, 2026 | 2.169M |
| August 14, 2026 | 2.179M |
| Date | Value |
|---|---|
| August 13, 2026 | 2.176M |
| August 12, 2026 | 2.169M |
| August 11, 2026 | 2.112M |
| August 10, 2026 | 2.092M |
| August 07, 2026 | 2.023M |
| August 06, 2026 | 1.815M |
| August 05, 2026 | 1.790M |
| August 04, 2026 | 1.838M |
| August 03, 2026 | 1.821M |
| July 31, 2026 | 1.897M |
| July 30, 2026 | 1.897M |
| July 29, 2026 | 1.891M |
| July 28, 2026 | 1.897M |
| July 27, 2026 | 1.845M |
| July 24, 2026 | 1.841M |
| July 23, 2026 | 1.851M |
| July 22, 2026 | 1.837M |
| July 21, 2026 | 1.840M |
| July 20, 2026 | 1.836M |
| July 17, 2026 | 1.859M |
| July 16, 2026 | 1.881M |
| July 15, 2026 | 1.874M |
| July 14, 2026 | 1.909M |
| July 13, 2026 | 1.914M |
| July 10, 2026 | 1.893M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Incyte Corp. | 1.356M |
| AVITA Medical, Inc. | 628696.4 |
| BioCryst Pharmaceuticals, Inc. | 4.142M |
| Neurocrine Biosciences, Inc. | 1.156M |
| Iovance Biotherapeutics, Inc. | 15.89M |